Acureon Pharmaceuticals Inc Berwyn, PA - 19312

Acureon Pharmaceuticals Inc is categorized under Wholesale Pharmaceutical Products in Berwyn, PA and active since 2006.

Acureon Pharmaceuticals Inc was established in 2006, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Wholesale Pharmaceutical Products business, which does work in the B2B market, and is classified as a Wholesale Pharmaceutical Products, under code number 424210 by the NAICS.

If you are seeking more information, feel free to contact Matthew Gantz at the company’s single location by writing to 1055 Westlakes Drive # 300, Berwyn, Pennsylvania PA 19312 or by phoning (610) 727-3891. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Acureon Pharmaceuticals Inc
Contact Person: Matthew Gantz
Address: 1055 Westlakes Drive # 300, Berwyn, Pennsylvania 19312
Phone Number: (610) 727-3891
Annual Revenue (USD): $100.000 to $499.999
Founded: 2006
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Wholesale Pharmaceutical Products
SIC Code: 5122
NAICS Code: 424210
Share This Business:

Acureon Pharmaceuticals Inc was started in 2006 to provide professional Wholesale Pharmaceutical Products under the SIC code 5122 and NAICS code 424210. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.

Feel free to contact Matthew Gantz for inquiries that concern Acureon Pharmaceuticals Inc by calling the company number (610) 727-3891, as your correspondence is most welcome. Additionally, the physical location of the single location of Acureon Pharmaceuticals Inc can be found at the coordinates as well as the street address 1055 Westlakes Drive # 300 in Berwyn, Pennsylvania 19312.

For its online presence, you may visit Acureon Pharmaceuticals Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.